[DOI] [PubMed] [Google Scholar] 29.Clerk LH, Vincent MA, Barrett EJ, Lankford MF, Lindner JR
And like anything you put in your body, they have some risks to be aware of
"You may start to see results within the first week or month, but some people do need a higher dose over time," she said
Its real bonus is in its straightforward use
Additional indications Knee osteoarthritis, sleep apnea, MASLD, cardiovascular outcomes, and chronic low back pain would follow based on their respective trial timelines This mirrors how Lilly handled tirzepatide: Mounjaro was approved for diabetes first (May 2022), followed by Zepbound for obesity (November 2023)
List conservative efforts tried: supervised weight management, specific exercise programs, for example, three months of supervised gym-based resistance training three times per week, compression therapy, physical therapy, medications, or manual lymphatic drainage